Literature DB >> 15520527

Accumulation of sulfatide in neuronal and glial cells of arylsulfatase A deficient mice.

Marie Molander-Melin1, Zarah Pernber, Sebastian Franken, Volkmar Gieselmann, Jan-Eric Månsson, Pam Fredman.   

Abstract

Arylsulfatase A (ASA) degrades sulfatide, seminolipid and lactosylceramide sulfate, glycolipids recognized by the Sulph I antibody although sulfatide is considered the main antigen. Sulfatide is myelin associated but studies have shown a minor distribution also in non-myelin forming cells. The aim of this work was to further study sulfatide in neurons and astrocytes by immunohistochemistry, facilitated by investigation of tissue from adult ASA deficient (ASA -/-) mice. Cells with a low presence of sulfatide might be detected due to lack of ASA activity and accumulation of Sulph I antigens. Sulfatide positive astrocytes and neurons were more numerous and intensely stained in ASA -/- mice, demonstrating a sulfatide accumulation compared to controls. Sulph I staining was especially increased in the molecular layer of cerebellum, in which Purkinje cell dendrites displayed an altered morphology, and in layer IV-VI of cerebral cortex. In hippocampus, immunostaining was found in neuronal cytoplasm in ASA -/- but in nuclear membranes of control mice. We observed a gray matter astrogliosis, which appeared to be associated to sulfatide accumulation. In addition, the developmental change (<20 months) of Sulph I antigens, galactosylceramide, phospholipids and cholesterol were followed by lipid analyses which verified sulfatide and seminolipid accumulation in adult ASA -/- mice, although no lactosylceramide sulfate could be detected. In addition to demonstrating sulfatide in neurons and astrocytes, this study supports the value of ASA -/- mice as a model for metachromatic leukodystrophy and suggests that accumulation of sulfatide beyond myelin might contribute to the pathology of this disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15520527     DOI: 10.1023/B:NEUR.0000046572.53905.2c

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  22 in total

1.  Toward a better understanding of brain lesions during metachromatic leukodystrophy evolution.

Authors:  A Martin; C Sevin; C Lazarus; C Bellesme; P Aubourg; C Adamsbaum
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-26       Impact factor: 3.825

Review 2.  Gene therapy for metachromatic leukodystrophy.

Authors:  Jonathan B Rosenberg; Stephen M Kaminsky; Patrick Aubourg; Ronald G Crystal; Dolan Sondhi
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

3.  Comparative efficacy and safety of multiple routes of direct CNS administration of adeno-associated virus gene transfer vector serotype rh.10 expressing the human arylsulfatase A cDNA to nonhuman primates.

Authors:  Jonathan B Rosenberg; Dolan Sondhi; David G Rubin; Sébastien Monette; Alvin Chen; Sara Cram; Bishnu P De; Stephen M Kaminsky; Caroline Sevin; Patrick Aubourg; Ronald G Crystal
Journal:  Hum Gene Ther Clin Dev       Date:  2014-08-21       Impact factor: 5.032

4.  Chronic caloric restriction attenuates a loss of sulfatide content in PGC-1α-/- mouse cortex: a potential lipidomic role of PGC-1α in neurodegeneration.

Authors:  Michael A Kiebish; Dee M Young; John J Lehman; Xianlin Han
Journal:  J Lipid Res       Date:  2011-11-23       Impact factor: 5.922

Review 5.  Pathology and current treatment of neurodegenerative sphingolipidoses.

Authors:  Matthias Eckhardt
Journal:  Neuromolecular Med       Date:  2010-08-22       Impact factor: 3.843

6.  Animal models of human cerebellar ataxias: a cornerstone for the therapies of the twenty-first century.

Authors:  Mario Manto; Daniele Marmolino
Journal:  Cerebellum       Date:  2009-09       Impact factor: 3.847

7.  Layer-specific sulfatide localization in rat hippocampus middle molecular layer is revealed by nanoparticle-assisted laser desorption/ionization imaging mass spectrometry.

Authors:  Hiroshi Ageta; Sayaka Asai; Yuki Sugiura; Naoko Goto-Inoue; Nobuhiro Zaima; Mitsutoshi Setou
Journal:  Med Mol Morphol       Date:  2009-03-18       Impact factor: 2.309

Review 8.  Properties, metabolism and roles of sulfogalactosylglycerolipid in male reproduction.

Authors:  Nongnuj Tanphaichitr; Kessiri Kongmanas; Kym F Faull; Julian Whitelegge; Federica Compostella; Naoko Goto-Inoue; James-Jules Linton; Brendon Doyle; Richard Oko; Hongbin Xu; Luigi Panza; Arpornrad Saewu
Journal:  Prog Lipid Res       Date:  2018-08-25       Impact factor: 16.195

Review 9.  The pathogenic implication of abnormal interaction between apolipoprotein E isoforms, amyloid-beta peptides, and sulfatides in Alzheimer's disease.

Authors:  Xianlin Han
Journal:  Mol Neurobiol       Date:  2010-01-07       Impact factor: 5.590

10.  Apolipoprotein E mediates sulfatide depletion in animal models of Alzheimer's disease.

Authors:  Hua Cheng; Yunhua Zhou; David M Holtzman; Xianlin Han
Journal:  Neurobiol Aging       Date:  2008-08-31       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.